2023
DOI: 10.1016/j.tox.2022.153412
|View full text |Cite
|
Sign up to set email alerts
|

Prediction of drug-induced mitochondrial dysfunction using succinate-cytochrome c reductase activity, QSAR and molecular docking

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 76 publications
0
5
0
Order By: Relevance
“…The total number of molecular descriptors was reduced based on specific criteria. These criteria included: 1) Removing descriptors with a standard deviation less than 0.001, 2) Eliminating descriptors with at least one missing value, 3) Removing descriptors with constant values, and 4) Removing descriptors that were constant across all molecules or highly correlated (R ≥ 0.9) [33][34][35] . As a result, a total of 321 descriptors were obtained for the calculation of mixture descriptors according to Eq.…”
Section: Data Set and Calculation Of Mixture Molecular Descriptorsmentioning
confidence: 99%
“…The total number of molecular descriptors was reduced based on specific criteria. These criteria included: 1) Removing descriptors with a standard deviation less than 0.001, 2) Eliminating descriptors with at least one missing value, 3) Removing descriptors with constant values, and 4) Removing descriptors that were constant across all molecules or highly correlated (R ≥ 0.9) [33][34][35] . As a result, a total of 321 descriptors were obtained for the calculation of mixture descriptors according to Eq.…”
Section: Data Set and Calculation Of Mixture Molecular Descriptorsmentioning
confidence: 99%
“…For this reason, developing drugs (antibiotics, anti-fungal agents, or anti-parasite agents) acting as specific bc 1 inhibitors is of commercial interest due to their use in medicine or agriculture to control diseases or cure severe infections. According to the state-of-the-art literature, specific bc 1 inhibitors are divided into three classes based on their points of action [45], such as (i) complex III Q i inhibitors (antimycin A, amisulbrom, cyazofamid); (ii) complex III Q 0 inhibitors (stigmatellin, ametoctradin, azoxystrobin); and (iii) dual site inhibitors (ascochlorin). Moreover, based on in vivo studies, Aureliano et al [46] pointed out that mitochondria might be a target for DV units that could affect its bioenergetics through different toxicity mechanisms by blocking the respiratory electron transport chain and acting as an antimycin A-like inhibitor.…”
Section: Molecular Docking Studiesmentioning
confidence: 99%
“…While this approach has proven that it can accurately predict numerous kinds of drug-induced toxicity such as general cytotoxicity (3), mitotoxicity (4) or even rhabdomyolysis (a fatal myopathy characterized by the breakdown of muscle tissue) (5,6) , it is still subject to some limitations. For instance, a QSPR model trained on a chemical family or specific scaffold can still be challenged by an intensively studied phenomenon called the activity cliff, where the observed property (such as toxicity) can sharply decrease/increase with only a slight displacement in the chemical space, and therefore adding complexity to a predictive model (7).…”
Section: Introductionmentioning
confidence: 99%